Position in MRNA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$44,764,960
+$28,002,844 QoQ
Shares Held
881,200
+55.0% QoQ
Ownership
0.222%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,467,670,450 across 330 Biotechnology names. MRNA ranks #15 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,726,993 | $588,750,729 | |
| 2 | INCY |
Incyte Corp
|
3,651,532 | $343,682,191 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
5,682,783 | $229,072,982 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
421,688 | $188,300,559 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
819,374 | $154,902,654 | |
| 6 | GMAB |
Genmab A/S
|
4,414,550 | $118,442,376 | |
| 7 | INVA |
Innoviva, Inc.
|
4,055,632 | $94,496,225 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
1,036,495 | $64,988,236 |
All Filings in MRNA
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $44,764,960 | 881,200 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $16,762,116 | 568,400 | Shares | Sole | 2026-02-12 | |
| 2025-06-30 | $27,697,601 | 1,003,900 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $38,558,835 | 1,360,100 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $42,027,317 | 1,010,758 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $20,737,349 | 310,300 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $10,200,625 | 85,900 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $11,487,168 | 107,800 | Shares | Sole | 2024-05-13 | |
| 2023-06-30 | $23,898,928 | 196,699 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $51,712,228 | 336,712 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $9,333,773 | 51,964 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $113,879,598 | 963,041 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $312,004,541 | 2,184,141 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $657,719,686 | 3,818,180 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $465,728,713 | 1,833,722 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $769,621,090 | 1,999,743 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $749,222,920 | 3,188,454 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $214,172,522 | 1,635,529 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $183,107,076 | 1,752,724 | Shares | Sole | 2021-02-10 | |
| 2020-06-30 | $20,251,834 | 315,400 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||